Search Results
Apr 16, 2026, 14:25 ET How IBM Quantum is Enabling Healthcare and Biology Research
twelve research teams from around the world receiving access to a combined $40 million in funding. By March 2026, that group had narrowed to six Phase III finalists. Now, the winners have been announced.Wellcome
More news about: IBM
Apr 16, 2026, 12:15 ET INVESTOR DEADLINE: monday.com Ltd. (MNDY) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
expansion within existing accounts and longer enterprise sales cycles, making monday.com's $1.8 billion 2027 target increasingly unlikely to be met; and (iii) defendants misled investors by providing the public with materially flawed statements of confidence and growth projections which did not account for
More news about: Robbins Geller Rudman & Dowd LLP
Apr 16, 2026, 11:05 ET INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
share, compared to $1.853 billion or $1.25 per share a year ago, and delivered full year adjusted EPS of $3.06, compared to $2.51 a year ago"; and (iii) Boston Scientific "[r]eported GAAP net income attributable to Boston Scientific common stockholders of $0.45 per share, compared to the company's guidance
More news about: Robbins Geller Rudman & Dowd LLP
Apr 16, 2026, 11:03 ET /C O R R E C T I O N -- Boehringer Ingelheim/
being evaluated in ongoing trials, across a range of earlier stages and advanced solid tumors with HER2 alterations. Beamion LUNG-2 is an ongoing Phase III controlled study evaluating zongertinib as a first-line treatment for patients with advanced NSCLC that has HER2 tyrosine kinase domain mutations (
More news about: Boehringer Ingelheim
Apr 16, 2026, 10:58 ET /C O R R E C T I O N -- JinkoSolar Holding Co., Ltd./
in fair value of convertible notes issued by Jinko Solar Co., Ltd. ("Jiangxi Jinko") in 2023, (ii) the change in fair value of long-term investment, (iii) share-based compensation expenses, and (iv) the impairment of long-lived assets, compared with adjusted net loss attributable to JinkoSolar Holding
More news about: JinkoSolar Holding Co., Ltd.
Apr 16, 2026, 10:05 ET Circle BMW Earns Back-to-Back BMW Center of Excellence Awards -- and Receives BMW's First-Ever Regional Red Belt Award
unwavering dedication to providing an outstanding experience for every client who walks through our doors or uses our mobile service," said Tom DeFelice III, center operator of Circle BMW. "We're never satisfied with the status quo. We are always looking for new ways to improve our operations to better serve
More news about: Circle BMW
Apr 16, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP
action]On March 13, 2026, Immutep issued a press release "announc[ing] that the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod alfa ('efti') in patients in 1st line non-small cell lung cancer has recommended the discontinuation of the trial
More news about: Pomerantz LLP
Apr 16, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Pinterest, Inc. and Certain Officers - PINS
States ("U.S.") tariffs on the macroeconomic environment in which the Company operated, including the foreseeable impact on its advertising partners; (iii) the impact of the foregoing on Pinterest's advertising revenues was significant enough that Pinterest was facing and/or likely to face an imminent restructuring;
More news about: Pomerantz LLP
Apr 16, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR
applicable instructions and protocol standards; (ii) the foregoing was likely to have a significant negative impact on the REZOLVE-AA trial's results; (iii) accordingly, the REZOLVE-AA trial's overall integrity and prospects were overstated; and (iv) as a result, Defendants' public statements were materially
More news about: Pomerantz LLP
Apr 16, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Enphase Energy, Inc. and Certain Officers - ENPH
its ability to manage its channel inventory; (ii) Enphase overstated its ability to mitigate effects arising from the termination of the 25D Credit; (iii) accordingly, Enphase overstated its financial and operational prospects; and (iv) as a result, the Company's public statements were materially false
More news about: Pomerantz LLP
Apr 16, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against ODDITY Tech Ltd. and Certain Officers - ODD
the foregoing significantly increased Oddity's customer acquisition costs, thereby negatively impacting Oddity's business and financial prospects; (iii) accordingly, Defendants overstated the overall strength, stability, and sustainability of Oddity's digital operating model and/or market position; and
More news about: Pomerantz LLP
Apr 16, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA
ALLELE study, made it unlikely that the FDA would approve the tabelecleucel BLA; (ii) accordingly, tabelecleucel's regulatory prospects were overstated; (iii) the aforementioned manufacturing issues also subjected Atara to a heightened risk of regulatory scrutiny, as well as jeopardized its ongoing clinical
More news about: Pomerantz LLP
Apr 16, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Upstart Holdings, Inc. and Certain Officers - UPST
performing its risk-separation processes; (ii) accordingly, Model 22's overall accuracy and propensity to increase loan approval rates was overstated; (iii) Model 22's overly conservative assessment of credit and macroeconomic conditions was having a significant negative impact on Upstart's revenue results,
More news about: Pomerantz LLP
Apr 16, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Gemini Space Station, Inc. and Certain Officers - GEMI
platform; (ii) Gemini had overstated its commitment to and/or the viability of growing its business through expanding its international operations; (iii) accordingly, Gemini's post-IPO financial and business prospects were overstated; (iv) all of the foregoing raised a non-speculative risk that Gemini
More news about: Pomerantz LLP
Apr 16, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Babcock & Wilcox Enterprises, Inc. and Certain Officers - BW
Applied Digital did not need the products and services that B&W would purportedly supply pursuant to the Power Generation LNTP and Contract; (iii) the foregoing, at the very least, would raise questions about the parties' actual intent behind entering into the Power Generation LNTP and Contract,
More news about: Pomerantz LLP
Apr 16, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Lakeland Industries, Inc. and Certain Officers - LAKE
these businesses on Lakeland's financial results, as well as the overall strength and quality of Pacific Helmets' and Jolly's respective operations; (iii) Lakeland's business and financial results were significantly deteriorating because of, inter alia, tariff-related headwinds and timing, certification
More news about: Pomerantz LLP
Apr 16, 2026, 09:24 ET SMR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds NuScale (SMR) Investors of Securities Class Action Deadline on April 20, 2026
of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (iii) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience
More news about: Faruqi & Faruqi, LLP
Apr 16, 2026, 09:15 ET DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
developing, manufacturing, and launching new products and services; (ii) customer uptake of, and satisfaction with, new products and services; and (iii) legislative, regulatory and economic developments, together with other factors detailed in our filings with the Securities and Exchange Commission,
More news about: Illumina, Inc.
Apr 16, 2026, 09:05 ET INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
with Anktiva to be cancer-free for the long term, when this has not been demonstrated"; (ii) the claim that Anktiva is a cancer vaccine was false; and (iii) ImmunityBio's Executive Chairman and Global Scientific and Medical Officer, defendant Dr. Patrick Soon-Shion, materially overstated Anktiva's capabilities.The
More news about: Robbins Geller Rudman & Dowd LLP
Apr 16, 2026, 08:57 ET ODD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Oddity Tech (ODD) Investors of Securities Class Action Deadline on May 11, 2026
the foregoing significantly increased Oddity's customer acquisition costs, thereby negatively impacting Oddity's business and financial prospects; (iii) accordingly, Defendants overstated the overall strength, stability, and sustainability of Oddity's digital operating model and/or market position; and
More news about: Faruqi & Faruqi, LLP
Apr 16, 2026, 08:11 ET Delska nimmt in Riga eines der modernsten und nachhaltigsten Rechenzentren des Baltikums in Betrieb
RechenzentrumDie 7.100 m² große modulare Anlage ermöglicht eine Erweiterung auf bis zu 30 MW. Sie unterstützt bis zu 250 kW pro Rack und erfüllt den Tier III-Standard, der eine Verfügbarkeit von 99,982 % gewährleistet.Die Anlage, die einen PUE-Wert von <1,3 anstrebt, wird mit erneuerbarer Energie aus
More news about: Delska
Apr 16, 2026, 08:07 ET YY Group Holding (NASDAQ: YYGH) Regains Compliance with Nasdaq Minimum Bid Price Requirement
hospitality and workforce markets in Southeast Asia, Hong Kong and other markets in which the Company operates (ii) capital and credit market volatility, (iii) local and global economic conditions, (iv) our anticipated growth strategies, (v) governmental approvals and regulations, and (vi) our future business
More news about: YY Group Holding Limited
Apr 16, 2026, 08:00 ET Decibel Reports Full-Year and Fourth Quarter 2025 Results: Revenue Grows 22% to $113 Million, Issues 2026 Guidance
relative stability in interest rates; (ii) limited relative deterioration in foreign exchange rates due to ongoing and evolving trade and tariff policies; (iii) limited overall impact to the Company's costs resulting from trade and tariff policies; (iv) limited overall impact to domestic and international demand
More news about: Decibel Cannabis Company Inc.
Apr 16, 2026, 08:00 ET Prologis Reports First Quarter 2026 Results
local economic and political climates and conditions; (ii) changes in global financial markets, interest rates and foreign currency exchange rates; (iii) increased or unanticipated competition for our properties; (iv) risks associated with acquisitions, dispositions and development of properties, including
More news about: Prologis, Inc.
Apr 16, 2026, 07:27 ET Natural Grocers® Celebrates North Dakota Day With a Special Gift and Savings April 19-21, 2026
details via {N}power email or app. Must present phone number at checkout to accumulate towards the minimum requirement in one transaction.[iii] Sign up by 4/16/2026 to receive this coupon via email or app. {N}power offers are available only to registered members and are subject to program
More news about: Natural Grocers by Vitamin Cottage, Inc.